Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Michael Dean Brown, President and CEO of Travel & Leisure Co. (TNL), sold 11,522 shares across April 14-15, 2026, after exercising an equal number of options. The sales generated $910416, while the option exercise cost $511346. After the transactions Brown holds 487303 shares. Separately, Wyndham Hotels & Resorts declared a quarterly dividend of $0…
Patrizio Vinciarelli, Vicor Corp chairman and CEO, sold $9,660,510 of company stock on April 15, 2026 under a Rule 10b5-1 plan adopted November 3, 2025. The transactions involved five separate blocks at prices between $191.1206 and $195.00 per share. Following the sales, Vinciarelli maintains significant ownership, holding 8,895,090 shares directly…
IDT Corp Chief Financial Officer Marcelo Fischer sold 5,000 shares of the company’s Class B common stock on April 14, 2026, for $50.50 per share, a transaction totaling $252,500. The company recently reported record results for the second quarter of fiscal 2026, with year-over-year growth across key metrics and an upward revision to Adjusted EBITDA…
Horizon Kinetics Asset Management LLC, a roughly 10% holder of Texas Pacific Land Corp (TPL), reported acquiring a single share on April 15, 2026, at $419.26. The firm now directly holds 3,435,497 TPL shares. Texas Pacific Land's stock was trading at $423.50, up 45% year-to-date, while some analysis flags a high P/E multiple. The company is also na…
Anne Delsanto, a director at Advanced Energy Industries Inc., sold 240 shares on April 15, 2026, generating $91,324. The trade was made under a pre-arranged Rule 10b5-1 plan adopted in March 2025. The stock has surged roughly 338% over the past year and was trading close to its 52-week high at the time of the sale. Advanced Energy reported stronger…
Dino DiPerna, senior vice president of Global R&D at Ciena Corporation, disclosed a sale of 2,829 shares on April 15, 2026, generating $1,334,693. The sale was made under a Rule 10b5-1 trading plan established July 11, 2025. Following the transaction DiPerna holds 42,460 Ciena shares, inclusive of unvested restricted and performance stock units. Se…
Saba Capital Management, L.P., a roughly 10% stakeholder in BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), sold 62,841 shares on April 15, 2026, at $14.68 per share for a total of $922,505. After the sale the firm retains 21,655,930 shares. The trust has posted a 25% total return over the last year and carries a 22.4% dividend yield; I…
Nordson CORP director Milton Mayo Morris sold 245 shares on April 15, 2026, generating $67,098 at $273.87 per share, according to a Form 4 filing. The sale occurred as the stock trades near $275 after a 54% gain over the past year. Nordson reported fiscal 2026 first-quarter EPS of $2.37 and revenue of $669 million, with organic sales growth of 7% a…
A director of Bonk, Inc. (NASDAQ: BNKK) bought 31,055 shares on April 9, 2026, at $2.82 per share, a transaction valued at $87,575. The company reported $3.2 million in first-quarter 2026 revenue, surpassing its internal quarterly target of $1.5 million. Filings list multiple ownership figures tied to the director through different entities.
Linda M. Biles, Executive Vice President - Finance at M-tron Industries, Inc. (NYSE:MPTI), disclosed the sale of 720 shares of common stock and 2,700 subscription rights in a Form 4 filed with the SEC. Both transactions are reported at a sale price of $0.0. The filing leaves Biles with a direct holding of 28,682 shares and notes outstanding stock o…
Aqua Capital, Ltd., a 10% owner of Energizer Holdings Inc. (NYSE: ENR), purchased 1,643 shares on April 14, 2026, for approximately $31,052. The transaction leaves Aqua Capital with 7,021,015 shares. The filing details a multi-layered ownership chain of indirect beneficial owners. Energizer reported Q1 fiscal 2026 results that beat estimates, yet s…
Vivani Medical director Williams Gregg purchased 1,587,301 shares at $1.26 each on April 15, 2026, for a total of $1,999,999. The common stock is trading at $1.14, below the director’s acquisition price, even as shares have risen 9.62% over the past week. Independent analysis flags VANI as overvalued on Fair Value metrics and notes ongoing volatili…
Travere Therapeutics' Chief Legal Officer, Elizabeth E. Reed, sold 46,600 shares of common stock on April 14 and 15, 2026, realizing roughly $2.13 million. The transactions followed option exercises and the vesting of performance restricted stock units tied to FDA approval of the company's drug Filspari. The equity trades occurred as the shares tra…
Travere Therapeutics Chief Financial Officer Christopher R. Cline reported a series of stock transactions between April 13 and April 15, 2026, that resulted in $348,974 of sales. The filings show discrete sales at prices ranging from $28.85 to $42.61, and the same filings show a separate award of 14,000 common shares at $0 following the vesting of …
Travere Therapeutics CEO Eric M. Dube sold 63,900 shares of common stock on April 15, 2026, in transactions totaling about $2.63 million. The disposals, carried out under a 10b5-1 plan adopted June 16, 2025, coincided with the stock trading near its 52-week high after a 181% gain over the past year. The sales covered tax obligations tied to newly v…
Travere Therapeutics Inc (NASDAQ:TVTX) Chief Commercial Officer Heerma Peter reported a sale of 7,215 shares on April 14, 2026, generating $302,516. The disposition followed a vesting of 14,000 performance-restricted stock units tied to FDA approval of Filspari, with the executive now holding 138,608 shares. The company’s stock is trading near a 52…
Travere Therapeutics Chief Medical Officer Jula Inrig sold 8,233 shares of common stock across April 14 and April 15, 2026, realizing roughly $345,893. The transactions followed the vesting of performance restricted stock units that delivered 14,000 shares on April 13. The insider sales, some executed to meet tax liabilities and including a pre-arr…
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman sold 20,406 shares on April 13 and April 15, 2026, for roughly $548,672 under a pre-arranged Rule 10b5-1 plan. Rodman also exercised options for 14,058 shares on April 13 and now holds 69,792 shares directly. The company reported fourth-quarter 2025 earnings with an EPS of -0.4, beati…
Mineralys Therapeutics Chief Executive Officer Jon Congleton sold 15,730 shares on April 13, 2026, generating roughly $421,979 at weighted-average prices between $26.81 and $26.96. The transaction was carried out under a Rule 10b5-1 plan adopted December 30, 2025. Congleton still holds 689,321 shares. The company reported Q4 2025 EPS of -0.4 versus…
Electronic Arts Chief People Officer Vijayanthimala Singh, through the Singh-Force Family Trust, sold 1,200 shares on April 15, 2026 at $203.25 each, totaling $243,900. The transaction occurred while EA shares traded close to a 52-week high and amid advancing merger steps and upbeat fiscal third-quarter results. The trust retains 28,760 shares foll…
Electronic Arts CEO Andrew Wilson sold 5,000 shares on April 15, 2026 under a previously arranged 10b5-1 plan, generating $1016058 in proceeds. The trade occurred while EA shares were trading close to a 52-week peak, amid strong quarterly results and progress on a proposed buyout by an investor consortium.
Ouster Chief Technology Officer Mark Frichtl sold 60,000 shares of common stock across April 14 and 15, 2026, for about $1.39 million, according to a Form 4 filing. The transactions were carried out under a pre-arranged Rule 10b5-1 plan and coincided with robust stock performance and solid fourth-quarter results reported by the company.
Laura Miele, President of EA Entertainment at Electronic Arts Inc. (NASDAQ: EA), sold 2,500 shares on April 15, 2026, for $508,025 under a previously established 10b5-1 plan. The transaction occurred as EA shares hovered close to their 52-week high, and follows strong fiscal third-quarter results and progress on a proposed merger with an investor c…
Annabelle G. Bexiga, a member of StoneX Group Inc.'s board, sold 1,500 shares of the company's common stock on April 15, 2026, for $152,865. The transaction occurred as the stock traded close to its 52-week high. The company has also announced several strategic moves to bolster cross-border payments, launched a securitization and capital markets pl…
Alignment Healthcare President Dawn Christine Maroney sold 30,000 shares on April 15, 2026, generating roughly $626,199 in proceeds. The sale was executed at prices between $20.76 and $21.07 per share. Maroney retains direct ownership of 1,028,813 shares. The transaction comes while the stock sits about 80% above its 52-week low and is noted by Inv…
